Skip to Content

Univasc Side Effects

Generic Name: moexipril

Note: This document contains side effect information about moexipril. Some of the dosage forms listed on this page may not apply to the brand name Univasc.

In Summary

More frequent side effects include: cough and dizziness. See below for a comprehensive list of adverse effects.

For the Consumer

Applies to moexipril: oral tablet

Along with its needed effects, moexipril (the active ingredient contained in Univasc) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking moexipril:

Less Common

  • Blurred vision
  • chills
  • confusion
  • cough
  • diarrhea
  • dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
  • fever
  • headache
  • joint pain
  • loss of appetite
  • muscle aches and pains
  • nausea
  • runny nose
  • shivering
  • sore throat
  • sweating
  • trouble sleeping
  • unusual tiredness or weakness
  • vomiting

Some side effects of moexipril may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More Common

  • Dry cough

Less Common

  • Body aches or pain
  • congestion
  • difficulty moving
  • dizziness
  • feeling of warmth
  • hoarseness
  • muscle cramping
  • muscle stiffness
  • rash
  • redness of the face, neck, arms, and upper chest
  • swollen joints
  • tender, swollen glands in the neck
  • trouble swallowing
  • voice changes

For Healthcare Professionals

Applies to moexipril: oral tablet

General

The most commonly reported adverse effects considered to be related to use of this drug were headache, cough, dizziness, fatigue, flushing, and rash.[Ref]

Other

Common (1% to 10%): Fatigue, flu syndrome, pain, peripheral edema, chest pain

Uncommon (0.1% to 1%): Fever

Rare (less than 0.1%): Malaise[Ref]

Respiratory

Common (1% to 10%): Cough, pharyngitis, upper respiratory tract infection, rhinitis, sinusitis

Rare (less than 0.1%): Bronchospasm, dyspnea

Frequency not reported: Eosinophilic pneumonitis[Ref]

Gastrointestinal

Common (1% to 10%): Diarrhea, dyspepsia, nausea

Uncommon (0.1% to 1%): Abdominal pain, constipation, vomiting

Rare (0.01% to 0.1%): Dry mouth

Very rare (less than 0.01%): Pancreatitis

Frequency not reported: Intestinal angioedema[Ref]

Nervous system

Common (1% to 10%): Headache, dizziness

Uncommon (0.1% to 1%): Cerebrovascular accident, transient ischemic attack, syncope

Rare (less than 0.1%): Numbness, paresthesia, balance disturbance, drowsiness, tingling sensations, alteration or transient loss of taste, tinnitus[Ref]

Renal

Common (1% to 10%): Serum creatinine increased, BUN increased

Rare (less than 0.1%): Acute renal failure, renal insufficiency[Ref]

Dermatologic

Common (1% to 10%): Rash

Uncommon (0.1% to 1%): Stevens-Johnson syndrome, toxic epidermal necrolysis, pruritus, urticaria, erythema multiforme, psoriasis-like efflorescence, pemphigus, alopecia

Rare (less than 0.1%): Angioedema

Frequency not reported: Sweating, photosensitivity[Ref]

Cardiovascular

Common (1% to 10%): Flushing

Uncommon (0.1% to 1%): Myocardial infarction, angina pectoris, rhythm disorder, tachycardia, palpitation, hypotension

Frequency not reported: Symptomatic hypotension, postural hypotension[Ref]

Musculoskeletal

Common (1% to 10%): Myalgia

Uncommon (0.1% to 1%): Arthralgia[Ref]

Genitourinary

Common (1% to 10%): Urinary frequency

Rare (less than 0.1%): Impotence

Frequency not reported: Oliguria[Ref]

Metabolic

Uncommon (0.1% to 1%): Appetite loss, uric acid elevated

Rare (less than 0.1%): Hyperkalemia

Frequency not reported: Hyponatremia[Ref]

Hematologic

Rare (0.01% to 0.1%): Anemia, neutropenia, eosinophilia, thrombocytopenia

Very rare (less than 0.01%): Pancytopenia, agranulocytosis, hemolytic anemia in patients with glucose-6-phosphate dehydrogenase deficiency, hemoglobin decreased, hematocrit decreased, platelets decreased, white cell count decreased[Ref]

Psychiatric

Rare (less than 0.1%): Confusion, depression, sleep disturbances

Frequency not reported: Nervousness, mood changes, anxiety[Ref]

Ocular

Rare (less than 0.1%): Vision blurred[Ref]

Hepatic

Very rare (less than 0.01%): Hepatitis, liver enzymes elevated, serum bilirubin elevated[Ref]

References

1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

2. "Product Information. Univasc (moexipril)." Schwarz Pharma, Mequon, WI.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Hide